A triterpenoid from wild bitter gourd inhibits breast cancer cells

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Bai, Li Yuan ^a,b   Chiu, Chang Fang ^a,b   Chu, Po Chen ^c,d   Lin, Wei Yu ^e   Chiu, Shih Jiuan ^f   Weng, Jing Ru ^g  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e Kinmen Hospital   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^g CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA,7BETA,25-TRIHYDROXYCUCURBITA-5,23(E)-DIEN-19-AL; ANTINEOPLASTIC AGENT; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT MEDICINAL PRODUCT; PROTEIN KINASE B; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TP53 PROTEIN, HUMAN; TRITERPENE;

APOPTOSIS; AUTOPHAGY; BIOSYNTHESIS; BREAST NEOPLASMS; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; HUMAN; MCF-7 CELL LINE; METABOLISM; MOMORDICA CHARANTIA; PATHOLOGY; PHOSPHORYLATION; PRECLINICAL STUDY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DRUG EVALUATION, PRECLINICAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; MCF-7 CELLS; MOMORDICA CHARANTIA; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PHYTOCHEMICALS; PLANT PREPARATIONS; PPAR GAMMA; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRITERPENES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84959481077     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22419     Document Type: Article

References (41)

1. Soerjomataram, I. et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet 380, 1840-1850 (2012).
2. Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA Cancer J Clin 64, 9-29 (2014).
3. Satoh, H. Pharmacological effectiveness of the active phytochemicals contained in foods and herbs. J Intercult Ethnopharmacol 3, 196-200 (2014).
4. Hosseini, A. & Ghorbani, A. Cancer therapy with phytochemicals: evidence from clinical studies. Avicenna J Phytomed 5, 84-97 (2015).
5. Saklani, A. & Kutty, S. K. Plant-derived compounds in clinical trials. Drug Discov Today 13, 161-171 (2008).
6. Chuang, C. Y. et al. Fractionation and identification of 9c, 11t, 13t-conjugated linolenic acid as an activator of PPARalpha in bitter gourd (Momordica charantia L.). J Biomed Sci 13, 763-772 (2006).
7. Cao, D. et al. Alpha-momorcharin (alpha-MMC) exerts effective anti-human breast tumor activities but has a narrow therapeutic window in vivo. Fitoterapia 100, 139-149 (2015).
8. Liaw, C. C. et al. 5beta,19-epoxycucurbitane triterpenoids from Momordica charantia and their anti-inflammatory and cytotoxic activity. Planta Med 81, 62-70 (2015).
9. Hsu, C. et al. Wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) extract and its bioactive components suppress Propionibacterium acnes-induced inflammation. Food Chem 135, 976-984 (2012).
10. Nhiem, N. X. et al. Inhibition of nuclear transcription factor-kappaB and activation of peroxisome proliferator-activated receptors in HepG2 cells by cucurbitane-type triterpene glycosides from Momordica charantia. J Med Food 15, 369-377 (2012).
11. Cheng, H. L., Kuo, C. Y., Liao, Y. W. & Lin, C. C. EMCD, a hypoglycemic triterpene isolated from Momordica charantia wild variant, attenuates TNF-alpha-induced inflammation in FL83B cells in an AMP-activated protein kinase-independent manner. Eur J Pharmacol 689, 241-248 (2012).
12. Weng, J. R. et al. Cucurbitane triterpenoid from Momordica charantia induces apoptosis and autophagy in breast cancer cells, in part, through peroxisome proliferator-activated receptor gamma Activation. Evid Based Complement Alternat Med 2013, 935675 (2013).
13. Gadang, V. et al. Dietary bitter melon seed increases peroxisome proliferator-activated receptor-gamma gene expression in adipose tissue, down-regulates the nuclear factor-kappaB expression, and alleviates the symptoms associated with metabolic syndrome. J Med Food 14, 86-93 (2011).
14. Shukla, S. et al. Cucurbitacin B alters the expression of tumor-related genes by epigenetic modifications in NSCLC and inhibits NNK-induced lung tumorigenesis. Cancer Prev Res (Phila) 8, 552-562 (2015).
15. Somasagara, R. R. et al. Bitter melon juice targets molecular mechanisms underlying gemcitabine resistance in pancreatic cancer cells. Int J Oncol 46, 1849-1857 (2015).
16. De Amicis, F. et al. Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signaling in human breast cancer cells. FASEB J 25, 3695-3707 (2011).
17. Manfredi, J. J. The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor. Genes Dev 24, 1580-1589 (2010).
18. Hayashi, S. I. et al. The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application. Endocr Relat Cancer 10, 193-202 (2003).
19. Ropero, S. & Esteller, M. The role of histone deacetylases (HDACs) in human cancer. Mol Oncol 1, 19-25 (2007).
20. Kawai, H., Li, H., Avraham, S., Jiang, S. & Avraham, H. K. Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha. Int J Cancer 107, 353-358 (2003).
21. Fan, J. et al. ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor. J Cancer Res Clin Oncol 134, 883-890 (2008).
22. Filomeni, G., Graziani, I., Rotilio, G. & Ciriolo, M. R. trans-Resveratrol induces apoptosis in human breast cancer cells MCF-7 by the activation of MAP kinases pathways. Genes Nutr 2, 295-305 (2007).
23. Li, Y. B. et al. Bisdemethoxycurcumin suppresses MCF-7 cells proliferation by inducing ROS accumulation and modulating senescence-related pathways. Pharmacol Rep 65, 700-709 (2013).
24. Ren, G. et al. Cucurbitacin B induces DNA damage and autophagy mediated by reactive oxygen species (ROS) in MCF-7 breast cancer cells. J Nat Med 69, 522-530 (2015).
25. Jaganathan, S. K. et al. Chemopreventive effect of apple and berry fruits against colon cancer. World J Gastroenterol 20, 17029-17036 (2014).
26. Ciou, S. Y., Hsu, C. C., Kuo, Y. H. & Chao, C. Y. Effect of wild bitter gourd treatment on inflammatory responses in BALB/c mice with sepsis. Biomedicine (Taipei) 4, 17 (2014).
27. Jilka, C., Strifler, B., Fortner, G. W., Hays, E. F. & Takemoto, D. J. In vivo antitumor activity of the bitter melon (Momordica charantia). Cancer Res 43, 5151-5155 (1983).
28. Chao, C. Y., Yin, M. C. & Huang, C. J. Wild bitter gourd extract up-regulates mRNA expression of PPARalpha, PPARgamma and their target genes in C57BL/6J mice. J Ethnopharmacol 135, 156-161 (2011).
29. Nerurkar, P. & Ray, R. B. Bitter melon: antagonist to cancer. Pharm Res 27, 1049-1053 (2010).
30. Ahmed, A. Prognostic and therapeutic role of nuclear factor-kappa B (NF-kappaB) in breast cancer. J Ayub Med Coll Abbottabad 22, 218-221 (2010).
31. Hosford, S. R. & Miller, T. W. Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways. Pharmgenomics Pers Med 7, 203-215 (2014).
32. Powell, E., Piwnica-Worms, D. & Piwnica-Worms, H. Contribution of p53 to metastasis. Cancer Discov 4, 405-414 (2014).
33. Royt, M., Mukherjee, S., Sarkar, R. & Biswas, J. Curcumin sensitizes chemotherapeutic drugs via modulation of PKC, telomerase, NF-kappaB and HDAC in breast cancer. Ther Deliv 2, 1275-1293 (2011).
34. Meeran, S. M., Patel, S. N., Li, Y., Shukla, S. & Tollefsbol, T. O. Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications. PLoS One 7, e37748 (2012).
35. Nourazarian, A. R., Kangari, P. & Salmaninejad, A. Roles of oxidative stress in the development and progression of breast cancer. Asian Pac J Cancer Prev 15, 4745-4751 (2014).
36. Mukhopadhyay, S., Panda, P. K., Sinha, N., Das, D. N. & Bhutia, S. K. Autophagy and apoptosis: where do they meet? Apoptosis 19, 555-566 (2014).
37. Mulholland, D. A., Sewram, V., Osborne, R., Pegel, K. H. & Connolly, J. D. Cucurbitane triterpenoids from the leaves of Momordica foetida. Phytochemisrty 45, 391-395 (1997).
38. Bai, L. Y. et al. BX795, a TBK1 inhibitor, exhibits antitumor activity in human oral squamous cell carcinoma through apoptosis induction and mitotic phase arrest. Eur J Pharmacol 769, 287-296 (2015).
39. Bai, L. Y. et al. OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis. Biochem Pharmacol 86, 1430-1440 (2013).
40. Bai, L. Y. et al. G15, a GPR30 antagonist, induces apoptosis and autophagy in human oral squamous carcinoma cells. Chem Biol Interact 206, 375-384 (2013).
41. Bai, L.-Y. et al. Alphitolic acid, an anti-inflammatory triterpene, induces apoptosis and autophagy in oral squamous cell carcinoma cells, in part, through a p53-dependent pathway. J Funct Foods 18, 368-378 (2015).